The introduction of PSMA PET/CT at Medya Diagnostic Center marks a significant advancement in prostate cancer diagnostics in Iraq, enhancing detection accuracy and staging capabilities, particularly for metastatic disease. This evidence concerns the gene FOLH1 and metastatic neoplasm.